MX352060B - Composicion dermatologica antimicrobiana topica. - Google Patents
Composicion dermatologica antimicrobiana topica.Info
- Publication number
- MX352060B MX352060B MX2015010606A MX2015010606A MX352060B MX 352060 B MX352060 B MX 352060B MX 2015010606 A MX2015010606 A MX 2015010606A MX 2015010606 A MX2015010606 A MX 2015010606A MX 352060 B MX352060 B MX 352060B
- Authority
- MX
- Mexico
- Prior art keywords
- dermatological composition
- topical antimicrobial
- composition
- antimicrobial dermatological
- topical
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 abstract 1
- 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención concierne a una composición utilizable en dermatología. La composición dermatológica antimicrobiana tópica para uso en medicina humana y veterinaria, comprende en asociación al menos un péptido antimicrobiano catiónico y ácido hialurónico de peso molecular medio o una de sus sales. Aplicación al tratamiento de las infecciones microbianas cutáneas, fanerianas o mucosas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1351766A FR3002452B1 (fr) | 2013-02-28 | 2013-02-28 | Composition dermatologique antimicrobienne topique |
PCT/FR2014/050383 WO2014131974A1 (fr) | 2013-02-28 | 2014-02-24 | Composition dermatologique antimicrobienne topique |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015010606A MX2015010606A (es) | 2016-04-21 |
MX352060B true MX352060B (es) | 2017-11-08 |
Family
ID=48613829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015010606A MX352060B (es) | 2013-02-28 | 2014-02-24 | Composicion dermatologica antimicrobiana topica. |
Country Status (23)
Country | Link |
---|---|
US (1) | US20150343014A1 (es) |
EP (2) | EP2961481B1 (es) |
JP (1) | JP6440637B2 (es) |
KR (1) | KR102193453B1 (es) |
AR (1) | AR094976A1 (es) |
BR (1) | BR112015020405B1 (es) |
CA (1) | CA2897518C (es) |
CY (1) | CY1119431T1 (es) |
DK (1) | DK2961481T3 (es) |
ES (1) | ES2641492T3 (es) |
FR (1) | FR3002452B1 (es) |
HR (1) | HRP20171446T1 (es) |
HU (1) | HUE034470T2 (es) |
LT (1) | LT2961481T (es) |
MA (1) | MA38344B1 (es) |
MX (1) | MX352060B (es) |
PL (1) | PL2961481T3 (es) |
PT (1) | PT2961481T (es) |
RU (1) | RU2668827C2 (es) |
SI (1) | SI2961481T1 (es) |
TN (1) | TN2015000282A1 (es) |
UA (1) | UA115894C2 (es) |
WO (1) | WO2014131974A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016535781A (ja) | 2013-11-03 | 2016-11-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 経皮薬物送達のためのイオン性液体 |
WO2017098474A1 (en) * | 2015-12-09 | 2017-06-15 | Universidade Do Minho | Antimicrobial peptide-loaded hyaluronic acid-based formulations, method of production and uses thereof |
US9439917B1 (en) * | 2015-12-28 | 2016-09-13 | Shetal Amit Shah | Anti-blepharitis compositions and their use |
JP7179354B2 (ja) * | 2016-08-29 | 2022-11-29 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 皮膚処置のためのイオン種に基づく局所処方物 |
JP7475018B2 (ja) * | 2017-07-25 | 2024-04-26 | ピアス株式会社 | 皮膚外用組成物 |
FR3132633B1 (fr) * | 2022-02-14 | 2024-04-12 | Thea Lab | Composition topique pour son utilisation dans le traitement des blépharites. |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU600483B2 (en) | 1986-03-14 | 1990-08-16 | Bio-Technology General Corporation | Heavy metal salts of hyaluronic acid |
SE9400036D0 (sv) | 1994-01-10 | 1994-01-10 | Pharmacia Ab | Low modecular weight hyaluronic acid |
CA2205771C (en) * | 1997-05-22 | 2002-05-14 | Hyal Pharmaceutical Corporation | Improved delivery of disease modifiers |
US6809181B2 (en) | 2000-06-01 | 2004-10-26 | University Of Iowa Research Foundation | Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide |
GB0103877D0 (en) * | 2001-02-16 | 2001-04-04 | King S College London | Novel Drug Delivery system |
SI20877A (sl) * | 2001-03-21 | 2002-10-31 | Kemijski inštitut | Lipopeptidi, njihova priprava in njihova uporaba za inaktivacijo gram-negativnih bakterij, gram-pozitivnih bakterij in za nevtralizacijo endotoksinov |
US6872705B2 (en) * | 2001-07-13 | 2005-03-29 | Allergan, Inc. | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions |
AU2002328203C1 (en) * | 2001-08-24 | 2009-01-08 | Migenix Inc. | Antimicrobial and anti-inflammatory peptides |
US20050196370A1 (en) * | 2003-03-18 | 2005-09-08 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
PT2103694E (pt) * | 2003-08-15 | 2011-07-26 | Univ South Florida | Materiais e métodos para a captura de patogénios e a remoção de ácido aurintricarboxílico de uma amostra |
CA2541856A1 (en) * | 2003-10-17 | 2005-05-12 | Regents Of The University Of Minnesota | Modified polypeptides with therapeutic activity and methods of use |
DK1853620T3 (da) * | 2005-02-09 | 2012-03-26 | Helix Biomedix Inc | Antimikrobielle hexapeptider |
EP1896386B1 (en) * | 2005-06-08 | 2012-09-05 | Cangene Corporation | Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria |
FR2894827B1 (fr) | 2005-12-21 | 2010-10-29 | Galderma Res & Dev | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
WO2009117473A2 (en) * | 2008-03-18 | 2009-09-24 | Massachusetts Institute Of Technology | Structures including antimicrobial peptides |
AU2010205751B2 (en) * | 2009-01-13 | 2013-05-02 | Pergamum Ab | Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation |
WO2010109284A1 (en) * | 2009-03-27 | 2010-09-30 | University Of Manitoba | Antimicrobial cationic lipo-beta-peptides |
FR2954945B1 (fr) | 2010-01-04 | 2012-01-06 | Oreal | Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique |
JP2013521300A (ja) * | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法 |
CN102552889A (zh) * | 2010-12-27 | 2012-07-11 | 上海高科联合生物技术研发有限公司 | 一种生物杀菌滴眼液制剂 |
RU2460532C1 (ru) * | 2011-04-28 | 2012-09-10 | Учреждение Российской академии наук Институт энергетических проблем химической физики РАН | Препарат, ускоряющий ранозаживление |
FR2978664B1 (fr) * | 2011-08-04 | 2014-01-10 | Petcare Innovation | Composition antiseptique |
-
2013
- 2013-02-28 FR FR1351766A patent/FR3002452B1/fr not_active Expired - Fee Related
-
2014
- 2014-02-24 US US14/760,781 patent/US20150343014A1/en not_active Abandoned
- 2014-02-24 KR KR1020157023374A patent/KR102193453B1/ko active IP Right Grant
- 2014-02-24 UA UAA201508442A patent/UA115894C2/uk unknown
- 2014-02-24 EP EP14718638.1A patent/EP2961481B1/fr active Active
- 2014-02-24 DK DK14718638.1T patent/DK2961481T3/en active
- 2014-02-24 BR BR112015020405-8A patent/BR112015020405B1/pt not_active IP Right Cessation
- 2014-02-24 HU HUE14718638A patent/HUE034470T2/en unknown
- 2014-02-24 CA CA2897518A patent/CA2897518C/fr not_active Expired - Fee Related
- 2014-02-24 ES ES14718638.1T patent/ES2641492T3/es active Active
- 2014-02-24 WO PCT/FR2014/050383 patent/WO2014131974A1/fr active Application Filing
- 2014-02-24 RU RU2015140996A patent/RU2668827C2/ru active
- 2014-02-24 SI SI201430393T patent/SI2961481T1/en unknown
- 2014-02-24 PL PL14718638T patent/PL2961481T3/pl unknown
- 2014-02-24 JP JP2015559537A patent/JP6440637B2/ja not_active Expired - Fee Related
- 2014-02-24 EP EP17163754.9A patent/EP3287171A1/fr not_active Withdrawn
- 2014-02-24 MA MA38344A patent/MA38344B1/fr unknown
- 2014-02-24 MX MX2015010606A patent/MX352060B/es active IP Right Grant
- 2014-02-24 LT LTEP14718638.1T patent/LT2961481T/lt unknown
- 2014-02-24 PT PT147186381T patent/PT2961481T/pt unknown
- 2014-03-05 AR ARP140100691A patent/AR094976A1/es unknown
-
2015
- 2015-06-18 TN TNP2015000282A patent/TN2015000282A1/fr unknown
-
2017
- 2017-09-26 HR HRP20171446TT patent/HRP20171446T1/hr unknown
- 2017-09-27 CY CY20171101017T patent/CY1119431T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
UA115894C2 (uk) | 2018-01-10 |
LT2961481T (lt) | 2017-10-25 |
CA2897518A1 (fr) | 2014-09-04 |
PL2961481T3 (pl) | 2018-01-31 |
MX2015010606A (es) | 2016-04-21 |
JP6440637B2 (ja) | 2018-12-19 |
US20150343014A1 (en) | 2015-12-03 |
BR112015020405A2 (pt) | 2017-07-18 |
AR094976A1 (es) | 2015-09-09 |
FR3002452A1 (fr) | 2014-08-29 |
SI2961481T1 (en) | 2018-01-31 |
FR3002452B1 (fr) | 2016-02-12 |
BR112015020405B1 (pt) | 2020-07-07 |
MA38344A1 (fr) | 2018-03-30 |
WO2014131974A1 (fr) | 2014-09-04 |
RU2015140996A (ru) | 2017-04-06 |
RU2015140996A3 (es) | 2018-03-12 |
HRP20171446T1 (hr) | 2017-12-29 |
PT2961481T (pt) | 2017-08-18 |
HUE034470T2 (en) | 2018-02-28 |
EP3287171A1 (fr) | 2018-02-28 |
DK2961481T3 (en) | 2017-10-09 |
CA2897518C (fr) | 2021-02-16 |
MA38344B1 (fr) | 2018-11-30 |
JP2016510017A (ja) | 2016-04-04 |
KR20150134325A (ko) | 2015-12-01 |
RU2668827C2 (ru) | 2018-10-02 |
EP2961481B1 (fr) | 2017-06-28 |
ES2641492T3 (es) | 2017-11-10 |
KR102193453B1 (ko) | 2020-12-21 |
EP2961481A1 (fr) | 2016-01-06 |
TN2015000282A1 (fr) | 2016-10-03 |
CY1119431T1 (el) | 2018-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2015000282A1 (fr) | Composition dermatologique antimicrobienne topique | |
HRP20200431T1 (hr) | Hidrogel na bazi polimera | |
MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
WO2015066647A3 (en) | Ionic liquids for transdermal drug delivery | |
BR112015027699A2 (pt) | Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico | |
BR112015016002A2 (pt) | compostos, composições farmacêuticas, complexos químicos e respectivos usos e método para tratar ou prevenir infecção bacteriana | |
MX2015010190A (es) | Metodos de tratamiento topico para infecciones microbianas. | |
BR112015027536A8 (pt) | composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente. | |
BR112014026058A2 (pt) | composições para tratamento tópico de infecções microbianas | |
MX2017015670A (es) | Composicion terapeutica. | |
WO2015038533A3 (en) | Sodium channel modulators for the treatment of pain and diabetes | |
WO2012017349A3 (en) | Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate | |
BR112015017519A2 (pt) | compostos e métodos para o tratamento de infecções bacterianas | |
PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
BR112013018365A2 (pt) | "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica" | |
FR2978665B1 (fr) | Composition antiseptique | |
WO2012149608A8 (en) | Prenylated hydroxystilbenes | |
GB201206486D0 (en) | Vesicular formulations and uses thereof | |
EA201401031A1 (ru) | Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей | |
MX2013010308A (es) | 2,4-pirimidindiaminas sustituidas para uso en lupus discoide. | |
UA113151C2 (xx) | Застосування композиції, що містить антимікробний поліпептид, у виробництві лікарського засобу | |
BR112016029761A8 (pt) | composições compreendendo um derivado de ácido quinolona carboxílico e agentes efervescentes, uso das mesmas e forma cristalina do referido derivado | |
TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. | |
TH181272A (th) | องค์ประกอบทางผิวหนังวิทยาต้านจุลชีพแบบทา | |
MX357829B (es) | Uso de un hidrolizado de caseína como agente antiherpético. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |